Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome) Latest Advances

Find the Latest Research About Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1465 publications

Morquio? Actually, Pseudo-Morquio.

Morquio? Actually, Pseudo-Morquio.

Journal: Internal medicine (Tokyo, Japan)
Published: August 10, 2026

Morquio syndrome masquerading as juvenile idiopathic Arthritis: A case report.

Morquio syndrome masquerading as juvenile idiopathic Arthritis: A case report.

Journal: Radiology case reports
Published: May 23, 2026

Growth Patterns in MPS IVA and MPS IIIA: A Longitudinal Single-Center Study.

Growth Patterns in MPS IVA and MPS IIIA: A Longitudinal Single-Center Study.

Journal: Journal of clinical medicine
Published: April 19, 2026

Long-term Natural History and Elosulfase Alfa Treatment for Mucopolysaccharidosis Type IVA: A Single-Center Study in the Czech Republic.

Long-term Natural History and Elosulfase Alfa Treatment for Mucopolysaccharidosis Type IVA: A Single-Center Study in the Czech Republic.

Journal: Research square
Published: April 03, 2026

Long-term follow-up and response to elosulfase alfa in mucopolysaccharidosis type IVA: a single-center cohort from the Czech Republic.

Long-term follow-up and response to elosulfase alfa in mucopolysaccharidosis type IVA: a single-center cohort from the Czech Republic.

Journal: Orphanet journal of rare diseases
Published: March 04, 2026

Comprehensive analysis of hearing function in Morquio A syndrome: Implications for diagnosis and management.

Comprehensive analysis of hearing function in Morquio A syndrome: Implications for diagnosis and management.

Journal: Molecular genetics and metabolism
Published: February 28, 2026

Early Versus Late Enzyme Replacement Therapy in Siblings With Morquio A Syndrome: Insights Into Therapeutic Timing.

Early Versus Late Enzyme Replacement Therapy in Siblings With Morquio A Syndrome: Insights Into Therapeutic Timing.

Journal: JIMD reports
Published: February 14, 2026

Natural History of Morquio A Syndrome.

Natural History of Morquio A Syndrome.

Journal: Journal of inherited metabolic disease
Published: January 30, 2026

Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B.

Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B.

Journal: International journal of molecular sciences
Published: January 30, 2026

Comprehensive characterization and translational implications of the GalnsR384C mouse model of Mucopolysaccharidosis IVA.

Comprehensive characterization and translational implications of the GalnsR384C mouse model of Mucopolysaccharidosis IVA.

Journal: Journal of human genetics
Published: January 26, 2026

AAV Gene Therapy for MPS IVA with Induction of Immune Tolerance via Oral Administration of Epitope Peptides of N-Acetylgalactosamine-6-sulfate Sulfatase.

AAV Gene Therapy for MPS IVA with Induction of Immune Tolerance via Oral Administration of Epitope Peptides of N-Acetylgalactosamine-6-sulfate Sulfatase.

Journal: International journal of molecular sciences
Published: January 25, 2026

Phenotypes of Elosulfase Alfa-Induced Immediate Hypersensitivity Reactions and Long-term Outcomes of Desensitization in Mucopolysaccharidosis IVA.

Phenotypes of Elosulfase Alfa-Induced Immediate Hypersensitivity Reactions and Long-term Outcomes of Desensitization in Mucopolysaccharidosis IVA.

Journal: International archives of allergy and immunology
Published: January 14, 2026
Showing 1-12 of 1,465

Last Updated: 09/26/2026